ARTICLE | Financial News
HepaVec raises $3.7 million
May 8, 2000 7:00 AM UTC
HepaVec (Berlin, Germany), a developer of hepatocyte-based drugs for liver disease, raised DM8 million in a venture financing. Investors included Techno-Venture Management; Dansk Kapitalanlaeg; and Al...